Evidence Base
The Value of Earlier Initiation of Anti-Amyloid Therapy for Alzheimer’s Disease
December 4, 2025
Featured Experts: Jack M. Chapel, PhD
Research
All Research Featured Research
Journal Article
Long-Term Value of Lecanemab to Individuals and Families
August 28, 2025
Featured Experts: Bryan Tysinger, PhD, Hanke Heun-Johnson, PhD, Julie Zissimopoulos, PhD
News
How a Gift Card Could Help Speed Up Alzheimer’s Clinical Research
August 22, 2025
Featured Experts: Mireille Jacobson, PhD, Doris Molina-Henry, PhD
Evidence Base
Alzheimer’s Breakthroughs Are on the Horizon — If We Can Get Patients Into Trials
July 7, 2025
Featured Experts: Phyllis Barkman Ferrell, DrPH, MBA
Journal Article
Real-World Evidence of Brexpiprazole Use and 6-Month Mortality, Hospitalization, and Emergency Department Visits Among Persons With Dementia
July 3, 2025
Featured Experts: Julie Zissimopoulos, PhD, Johanna Thunell, PhD, Mireille Jacobson, PhD, Sidra Haye, PhD, Bryan Tysinger, PhD, Geoffrey Joyce, PhD
Journal Article
Advancing the Science of Recruitment for Alzheimer’s Clinical Trials: Challenges and Opportunities
June 12, 2025
Featured Experts: Paul Aisen, MD, Desi Peneva, MS, Maria-Alice Manetas, Mireille Jacobson, PhD, Dana Goldman, PhD, Niranjan Bose, PhD, Phyllis Barkman Ferrell, DrPH, MBA, Rema Raman, PhD
Evidence Base
New Alzheimer’s Blood Tests Have the Potential to Supercharge Clinical Trials
May 27, 2025
Featured Experts: Phyllis Barkman Ferrell, DrPH, MBA, Desi Peneva, MS, Mireille Jacobson, PhD, Maria-Alice Manetas
News
U.S. Dementia Costs to Exceed $780 Billion This Year, USC-Led Research Finds
April 23, 2025
Featured Experts: Julie Zissimopoulos, PhD, Dana Goldman, PhD, Bryan Tysinger, PhD
Issue Brief
The Cost of Dementia in 2025
April 23, 2025
Featured Experts: Julie Zissimopoulos, PhD, Dana Goldman, PhD, Bryan Tysinger, PhD
Evidence Base
Who Will Use New Alzheimer’s Drugs? Addressing Barriers to Access Is Critical
April 17, 2025
Featured Experts: Julie Zissimopoulos, PhD
Journal Article
The Effect of US COVID-19 Excess Mortality on Social Security Outlays
February 18, 2025
Featured Experts: Hanke Heun-Johnson, PhD, Darius Lakdawalla, PhD, Bryan Tysinger, PhD
Evidence Base
Expanding Medicare Coverage for Cognitive Screening
December 12, 2024
Featured Experts: Joseph Grogan, JD
Journal Article
Use of Medications with Somnolence Adverse Effects and Somnolence Symptoms Among Older Adults in the U.S.
November 26, 2024
Featured Experts: Dima M. Qato, PharmD, MPH, PhD
Journal Article
Examining the Role of Community Engagement in Enhancing the Participation of Racial and Ethnic Minoritized Communities in Alzheimer’s Disease Clinical Trials; A Rapid Review
November 1, 2024
Featured Experts: Jevay Grooms, PhD, Doris Molina-Henry, PhD
CeASES-ADRD Pilot Project Awardees
June 27, 2024
News
Key USC Researchers’ Dementia Cost Model Aims to Help Patients, Families
June 26, 2024
Featured Experts: Julie Zissimopoulos, PhD, Dana Goldman, PhD, Bryan Tysinger, PhD, Hanke Heun-Johnson, PhD, Duncan Ermini Leaf, PhD, Johanna Thunell, PhD, Geoffrey Joyce, PhD, Sze-chuan Suen, PhD, Eileen Crimmins, PhD, Mireille Jacobson, PhD
Perspective
Access to New Alzheimer’s Treatments Bogged Down by Medicare Policy
June 17, 2024
Featured Experts: Joseph Grogan, JD
Journal Article
Reporting and Representation of Participant Demographic Information in Completed Alzheimer’s Disease Clinical Trials
May 15, 2024
Featured Experts: Mireille Jacobson, PhD, Olivia Wang, PhD